BBNX

Beta Bionics (BBNX)

About Beta Bionics (BBNX)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Details

Daily high

$13.66

Daily low

$12.90

Price at open

$13.47

52 Week High

$32.71

52 Week Low

$8.89

Market cap

582.9M

Dividend yield

0.00%

Volume

5,129

Avg. volume

1.7M

P/E ratio

-7.39

Beta Bionics News